- 收听数
- 8
- 性别
- 男
- 听众数
- 22
- 最后登录
- 2024-3-1
- 学历
- 博士
- QQ
 - UID
- 1120
- 阅读权限
- 90
- 帖子
- 7355
- 精华
- 0
- 在线时间
- 4421 小时
- 注册时间
- 2012-11-4
  
- 科研币
- 235
- 速递币
- 953
- 娱乐币
- 7847
- 文献值
- 1663
- 资源值
- 22
- 贡献值
- 6
|
发表于 2020-3-12 20:09:35
|显示全部楼层
速递书局
| 封面: |
 |
| 题名: |
Biosimilars: Design and Analysis of Follow-on Biologics |
| 作者: |
Shein-Chung Chow |
| 出版社: |
CRC Press |
| 出版日期: |
2019-10-23 |
| ISBN: |
9780367379728 |
| 附属页: |
齐全 |
| 书签: |
无 |
| 格式: |
清晰PDF |
| 内容简介: |
This is the first book entirely devoted to the design and analysis for assessment of biosimilarity and drug interchangeability of biosimilars, and test for comparability in manufacturing processes of biologic products. It covers all of the statistical issues that may occur in biosimilar studies under various study designs at various stages of research and development of biologic products"--"Biologic drug products are therapeutic moieties that are manufactured using a living system or organism. These are important life-saving drug products for patients with unmet medical needs. They also comprise a growing segment in the pharmaceutical industry. In 2007, for instance, worldwide sales of biological products reached $94 billion US dollars, accounting for about 15% of the pharmaceutical industry's gross revenue. Meanwhile, many biological products face losing their patents in the next decade"-- Read more... Abstract: "This is the first book entirely devoted to the design and analysis for assessment of biosimilarity and drug interchangeability of biosimilars, and test for comparability in manufacturing processes of biologic products. It covers all of the statistical issues that may occur in biosimilar studies under various study designs at various stages of research and development of biologic products"--"Biologic drug products are therapeutic moieties that are manufactured using a living system or organism. These are important life-saving drug products for patients with unmet medical needs. They also comprise a growing segment in the pharmaceutical industry. In 2007, for instance, worldwide sales of biological products reached $94 billion US dollars, accounting for about 15% of the pharmaceutical industry's gross revenue. Meanwhile, many biological products face losing their patents in the next decade |
| 求助帖链接: |
http://www.expaper.cn/forum.php?mod=viewthread&tid=240843 |
本帖子中包含更多资源
您需要 登录 才可以下载或查看，没有帐号？快速注册
|
发表于 2020-3-14 11:41:19
